Position in ESLA
as of Sep 30, 2025
· filed Nov 12, 2025
Position Value
$46,000
+$7,600 QoQ
Shares Held
223,099
0.0% QoQ
Ownership
0.513%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESLA Over Time
Shares Held
Position Value (USD)
Derivatives in ESLA
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
183,099
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Sep 30, 2025ATW SPAC MANAGEMENT LLC holds $46,000 across 7 Biotechnology names. ESLA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESLA |
Estrella Immunopharma, Inc.
This page
|
223,099 | $46,000 | |
| 2 | ICU |
SeaStar Medical Holding Corp
|
245,200 | $0 | |
| 3 | OSRH |
OSR Health, Inc.
|
311,040 | $0 | |
| 4 | TVGN |
Tevogen Inc.
|
25,000 | $0 | |
| 5 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
60,540 | $0 | |
| 6 | APLM |
Apollomics Inc.
|
373,715 | $0 | |
| 7 | CDT |
CDT Equity Inc.
|
250,000 | $0 |
All Filings in ESLA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 | $46,000 | 40,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $38,400 | 40,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $37,080 | 40,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $48,000 | 40,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $46,400 | 40,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $42,000 | 40,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $49,600 | 40,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,400 | 40,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||